Mind Capital Lease Obligations from 2010 to 2025
| MNMD Stock | USD 6.19 0.24 3.73% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 82.8 K | Current Value 86.9 K | Quarterly Volatility 35.2 K |
Check Mind Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mind Medicine's main balance sheet or income statement drivers, such as Interest Income of 12.1 M, Selling General Administrative of 25.7 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.79. Mind financial statements analysis is a perfect complement when working with Mind Medicine Valuation or Volatility modules.
Mind | Capital Lease Obligations |
Latest Mind Medicine's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Mind Medicine over the last few years. Mind Medicine capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Mind Medicine asset purchases. For example, Mind Medicine can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Mind Medicine control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Mind Medicine's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mind Medicine's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Mind Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 19,609 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 179.73 | |
| Mean Deviation | 29,413 | |
| Median | 0.00 | |
| Standard Deviation | 35,242 | |
| Sample Variance | 1.2B | |
| Range | 86.9K | |
| R-Value | 0.76 | |
| Mean Square Error | 564.1M | |
| R-Squared | 0.58 | |
| Significance | 0.0007 | |
| Slope | 5,618 | |
| Total Sum of Squares | 18.6B |
Mind Capital Lease Obligations History
About Mind Medicine Financial Statements
Mind Medicine stakeholders use historical fundamental indicators, such as Mind Medicine's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Mind Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mind Medicine's assets and liabilities are reflected in the revenues and expenses on Mind Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mind Medicine. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 82.8 K | 86.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Mind Medicine Correlation against competitors. For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.